Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: J Neurol Neurosurg Psychiatry. 2016 Nov 29;88(2):152–164. doi: 10.1136/jnnp-2016-314411

Table 1.

Summary data from all GWAS used in the current study

Disease/trait Total
N
# SNPs Reference
Frontotemporal dementia (FTD)—
IFGC phase I
6462 6 026 384 16
Frontotemporal dementia (FTD)—
IFGC phase II
6466 Illumina NeuroX
Chip
16
Alzheimer’s disease (AD)—phase I 54 162 7 055 881 23
Parkinson’s disease (PD) 17 352 7 689 524 24

GWAS, genome-wide association studies; IFGC, International FTD-Genomics Consortium.